These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 20420785)
1. [Analysis of prognostic factors of epithelial ovarian carcinoma]. Shao SL; Liu XS Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):132-6. PubMed ID: 20420785 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome. Grivas A; Lianos E; Internos I; Papaxoinis G; Tselepatiotis E; Ziras N; Athanasiou AE J BUON; 2010; 15(4):647-51. PubMed ID: 21229624 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
4. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
5. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma]. Zhao XD; Zhang Q; Zhang Y Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882 [TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of ovarian cancer associated with endometriosis. Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136 [TBL] [Abstract][Full Text] [Related]
8. A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study. Selle F; Pautier P; Lhommé C; Viens P; Fabbro M; Lokiec F; Gligorov J; Richard S; Provent S; Soares DG; Lotz JP Chemotherapy; 2016; 61(1):15-22. PubMed ID: 26528705 [TBL] [Abstract][Full Text] [Related]
9. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653 [TBL] [Abstract][Full Text] [Related]
11. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience. Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of radiotherapy for state I ovarian carcinoma]. Sheng X; Sun J; Zhou C Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332 [TBL] [Abstract][Full Text] [Related]
13. [Treatment and prognostic factors of epithelial ovarian cancer]. Wei L; Qian H; Li W Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study. Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604 [TBL] [Abstract][Full Text] [Related]
15. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811 [TBL] [Abstract][Full Text] [Related]
16. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy. Bamias A; Psaltopoulou T; Sotiropoulou M; Haidopoulos D; Lianos E; Bournakis E; Papadimitriou C; Rodolakis A; Vlahos G; Dimopoulos MA Cancer; 2010 Mar; 116(6):1462-8. PubMed ID: 20108307 [TBL] [Abstract][Full Text] [Related]
17. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining. Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666 [TBL] [Abstract][Full Text] [Related]
18. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management. Grønlund B Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448 [No Abstract] [Full Text] [Related]
19. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy]. Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733 [TBL] [Abstract][Full Text] [Related]
20. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]